Tuesday, January 13, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyzing Southland Holdings Q4 Earnings Performance

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Home Construction Stock Exchange
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Southland Holdings Q4 Earnings Breakdown

Southland Holdings (AMEX: SLND) recently disclosed its Q4 earnings, unveiling important details for investors to take note of. Here’s a breakdown of the key highlights:

Earnings Performance:
Southland Holdings fell short of estimated earnings by -700.0%, posting an EPS of $-0.12 as opposed to an expected $0.02.
Revenue saw a significant increase of $21.39 million compared to the same period last year.

Past Earnings Performance:
In the previous quarter, the company missed EPS by $0.02, leading to a 6.0% rise in the share price the following day.
A summary of Southland Holdings’ performance in recent quarters is as follows:

Quarter EPS Estimate EPS Actual Revenue Estimate (in millions) Revenue Actual (in millions)
Q3 2023 0.10 0.08 $300.65 $312.47
Q2 2023 0.34 -0.76 $257.00 $256.93
Q1 2023 -0.04 -0.03 $237.45 $274.83
Q4 2022 0.23 0.68 $338.47 $294.80

For more in-depth information and to keep track of all earnings releases for Southland Holdings, you can visit their quarterly results page.

This summary offers a comprehensive overview of Southland Holdings’ recent financial performance, providing valuable insights for investors to understand the company’s direction and market position.

SLND Stock Plummets 5.41% in One Day – Should Investors Be Worried?

On March 4, 2024, SLND stock experienced a significant drop in its price performance. The stock closed at $4.37, which was $0.25 lower than the previous market close, representing a 5.41% decrease for the day. SLND is currently trading near the bottom of its 52-week range and below its 200-day simple moving average, indicating a downward trend. In after-hours trading, the stock dropped an additional $0.04, suggesting investors may be losing confidence and selling off shares. It is important to monitor SLND’s performance in the coming days to see if it can rebound. Exercise caution when considering buying or holding SLND stock until there is more clarity on its price momentum and market conditions.

SLND Stock Shows Impressive Growth in Net Income and Earnings per Share

On March 4, 2024, SLND stock experienced a significant increase in both net income and earnings per share compared to the previous year and quarter. According to data from CNN Money, SLND reported a net income of $1.93 million over the course of the past year, which represents a staggering 1495.06% increase from the previous year. In the third quarter of the same year, SLND’s net income rose to $3.80 million, marking a 129.63% increase from the previous quarter.

Similarly, SLND’s earnings per share (EPS) also saw substantial growth over the same period. The EPS for the past year stood at $0.05, reflecting a remarkable 1479.49% increase from the previous year. In the third quarter of the year, the EPS rose to $0.08, representing a 129.02% increase from the previous quarter.

While the total revenue for SLND is currently unavailable, the impressive growth in net income and EPS suggests that the company has been performing well financially. Investors may view these positive financial indicators as a sign of potential growth and profitability for SLND in the future.

Tags: SLND
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DrugRetailers Stock Market Today

ThredUp Reports Strong Revenue Growth in Q4 2023 and Optimistic Outlook for 2024

Doctor on mobile phone

Health Tech Innovations: Transforming Healthcare Delivery and Monitoring

Revenue Operations: How Innovative Technology is Transforming Sales Strategies

Revenue Operations: How Innovative Technology is Transforming Sales Strategies

Recommended

Take-Two Stock

Take-Two Shares Reach Unprecedented Highs on Strong Game Releases

4 months ago
Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects

Analyzing Brady Corporations Historical Earnings Performance and Stock Price Changes

2 years ago
Greif Stock

Packaging Giant Greif Approaches Critical Earnings Milestone

5 months ago
Barrick Mining Stock

Barrick Gold Faces Potential Breakup Amid Activist Pressure

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Apex Critical Metals Advances to Core Drilling Phase

Xiaomi’s Three-Pronged Strategy for Ecosystem Growth

Chevron’s Volatile Path: Venezuela’s Promise Meets Market Realities

Eli Lilly Shares Face a Crucial Test After Stellar Run

Tilray’s Q2 Performance: Record Revenue Amid Diverging Segment Trends

Metaplanet’s Aggressive Bitcoin Acquisition Strategy Fuels Share Rally

Trending

Fiserv Stock
AI & Quantum Computing

Fiserv Embarks on Strategic AI Push Amid Leadership Reshuffle

by Robert Sasse
January 13, 2026
0

The financial technology giant Fiserv used the prominent NRF 2026 retail trade show in New York as...

Alphabet Stock

Alphabet Reaches Historic Valuation Milestone on Dual Strategic Wins

January 13, 2026
Sangamo Therapeutics Stock

A Regulatory Milestone Sparks Renewed Interest in Sangamo Therapeutics

January 13, 2026
Apex Critical Metals Stock

Apex Critical Metals Advances to Core Drilling Phase

January 13, 2026
Xiaomi Stock

Xiaomi’s Three-Pronged Strategy for Ecosystem Growth

January 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Fiserv Embarks on Strategic AI Push Amid Leadership Reshuffle
  • Alphabet Reaches Historic Valuation Milestone on Dual Strategic Wins
  • A Regulatory Milestone Sparks Renewed Interest in Sangamo Therapeutics

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com